Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion

The companies will share development and commercialization costs as well as potential future profits from the new drugs, they said.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。